Transcranial direct stimulation and fluoxetine for the treatment of depression.
Rigonatti
Sergio P
SP
Boggio
Paulo S
PS
Myczkowski
Martin L
ML
Otta
Emma
E
Fiquer
Juliana T
JT
Ribeiro
Rafael B
RB
Nitsche
Michael A
MA
Pascual-Leone
Alvaro
A
Fregni
Felipe
F
D003865:Major Depressive Disorder / Q000175:diagnosis / Q000188:drug therapy / Q000628:therapy*; D004311:Double-Blind Method; D005260:Female; D005473:Fluoxetine / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010555:Personality Inventory / Q000706:statistics & numerical data; D017397:Prefrontal Cortex / Q000502:physiology*; D011446:Prospective Studies; D011569:Psychiatric Status Rating Scales / Q000706:statistics & numerical data; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*; D050781:Transcranial Magnetic Stimulation / Q000379:methods*; D016896:Treatment Outcome
D005473:Fluoxetine; D017367:Selective Serotonin Reuptake Inhibitors